Return to homepagePandemic Pact

COVID-19 Vaccine Using Viral Vector System

Grant number: RF-TAA-2020-V04

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2020
    2021

  • Known Financial Commitments (USD)

    $417,865.9

  • Funder

    RIGHT Foundation

  • Principal Investigator

    Kunse Lee

  • Research Location

    41

  • Lead Research Institution

    SK Bioscience

  • Research Priority Alignment

    N/A

  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    Innovation

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Development of a measles virus (MV) and vesicular stomatitis virus (VSV) vector for COVID-19 DNA vaccine. DNA vaccine antigen targets spike protein (S) or nucleocapsid protein (N).